drugset / Trial / NCT00154050
High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to test the hypothesis that high dose candesartan treatment compared to quinapril is able to reduce intima hyperproliferation and the restenosis rate after stent angioplasty in peripheral occlusive artery disease.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan | Unknown | 32 mg | — |
| Subject | Quinapril | Small molecule | 20 mg | — |